Clinical Trials · NCT07858864

GLP-1 Receptor Agonist Use and Sarcopenia in Obese Individuals Without Diabetes

Phase
N/A
Recruitment status
Recruiting
Sponsor
Istanbul Saglik Bilimleri University
Enrollment
42
Start date
May 2026
Locations
1 site, Turkey (Türkiye)
Primary endpoint
Change in SARC-F (Strength, Assistance in walking, Rise from a chair, Climb stairs, and Falls) total score
View Tirzepatide compound reference